- VANUDIS - Biotech Company
- SkyAngle Building
- Max-Jarecki-Str. 21
- 69115 Heidelberg
- office@vanudis.net
- +49 6221 3919 0
MICHAELA ARNDT, PhD
co-founder of VANUDIS
Michaela is a biologist with established track record in antibody drug development starting from early discovery through production/CMC to the clinical translation of generated assets.
She is co-founder of VANUDIS and responsible for the operational management of the company. Michaela is Managing Director of Heidelberg ImmunoTherapeutics since its inception in 2016 where she is leading the clinical development of a humanized antibody against Herpes simplex infections previously been developed in her academic research group.
Prior to that she built a two decade spanning academic career at the National Cancer Institute (NCI) of the National Institute of Health (NIH)/United States, the West German Cancer Center in Essen, the National Center for Tumor Diseases Heidelberg (NCT), and the German Cancer Research Center (DKFZ) always with focus on therapeutic antibodies.